The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.

导出 OA

翻译打印收藏纠错

作者： Gregory S,Thomas ^[1] ; S James,Cullom ^[2] ; Therese M,Kitt ^[3] ; Kathleen M,Feaheny ^[4] ; Karthikeyan,Ananthasubramaniam ^[5] ; Robert J,Gropler ^[5] ; Diwakar,Jain ^[6] ; Randall C,Thompson ^[7]

作者单位： MemorialCare Heart & Vascular Institute, Long Beach Memorial, 2801 Atlantic Ave, Long Beach, CA, 90806, USA. gthomas1@memorialcare.org. ^[1] University of California, Irvine, CA, USA. gthomas1@memorialcare.org. ^[2] AdaptivePharma, Leawood, KS, USA. ^[3] University of Missouri, Columbia, MO, USA. ^[4] Astellas Pharma Global Development, Inc., Northbrook, IL, USA. ^[5] Department of Internal Medicine, Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI, USA. ^[6] Division of Radiological Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA. ^[7] Cardiovascular Nuclear Imaging Laboratory, New York Medical College, Westchester Medical Center, Valhalla, NY, USA. ^[8] Saint Luke's Mid America Heart Institute, Kansas City, MO, USA. ^[9] University of Missouri-Kansas City, Kansas City, MO, USA. ^[10]

关键词 Exercise myocardial perfusion imaging pharmacologic stress regadenoson vasodilator stress